Stratification of hypertensive COVID-19 patients by quantitative NMR spectroscopy of serum metabolites, lipoproteins and inflammation markers
Jasmin Kazenwadel, View ORCID ProfileGeorgy Berezhnoy, Claire Cannet, Hartmut Schäfer, Tobias Geisler, View ORCID ProfileAnne-Katrin Rohlfing, View ORCID ProfileMeinrad Gawaz, View ORCID ProfileUta Merle, View ORCID ProfileChristoph Trautwein
doi: https://doi.org/10.1101/2022.12.20.22283729
Jasmin Kazenwadel
1Werner Siemens Imaging Center, Department for Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany
Georgy Berezhnoy
1Werner Siemens Imaging Center, Department for Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany
Claire Cannet
2Bruker BioSpin GmbH, Applied Industrial and Clinical Division, Ettlingen, Germany
Hartmut Schäfer
2Bruker BioSpin GmbH, Applied Industrial and Clinical Division, Ettlingen, Germany
Tobias Geisler
3Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
Anne-Katrin Rohlfing
3Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
Meinrad Gawaz
3Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
Uta Merle
4Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany
Christoph Trautwein
1Werner Siemens Imaging Center, Department for Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted December 21, 2022.
Stratification of hypertensive COVID-19 patients by quantitative NMR spectroscopy of serum metabolites, lipoproteins and inflammation markers
Jasmin Kazenwadel, Georgy Berezhnoy, Claire Cannet, Hartmut Schäfer, Tobias Geisler, Anne-Katrin Rohlfing, Meinrad Gawaz, Uta Merle, Christoph Trautwein
medRxiv 2022.12.20.22283729; doi: https://doi.org/10.1101/2022.12.20.22283729
Stratification of hypertensive COVID-19 patients by quantitative NMR spectroscopy of serum metabolites, lipoproteins and inflammation markers
Jasmin Kazenwadel, Georgy Berezhnoy, Claire Cannet, Hartmut Schäfer, Tobias Geisler, Anne-Katrin Rohlfing, Meinrad Gawaz, Uta Merle, Christoph Trautwein
medRxiv 2022.12.20.22283729; doi: https://doi.org/10.1101/2022.12.20.22283729
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2657)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12254)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4116)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2666)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (854)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3899)
- Nursing (210)
- Nutrition (579)
- Oncology (2038)
- Ophthalmology (586)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6542)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (185)
- Urology (166)